Business & Regulation

We sit down with Siu Ping Lam, Director of Licensing Division at the UK's Medicines and MHRA.

Starting a bioanalytical research company after years working for Big Pharma has been daunting…

“The best-laid schemes o’mice an’ men” often go awry – and that can apply to your outsourcing plans.

What if we could treat bacterial infection earlier and without adding to drug resistance?

Changing your company name takes more than putting a new sign on the door.

Can certain buzzwords really sway public perceptions of a new drug?

Round and round she goes, where she stops nobody knows. How will the current merger and acquisition fever affect the industry?

Sitting Down With... John Talley, Chief Scientific Officer at Euclises Pharmaceuticals, St. Louis, USA.

How can the pharma industry capitalize on the growth potential of emerging markets?

Grant Lindman is director of Eli Lilly’s global anticounterfeiting operations and is passionate about fighting fake medicines.